Summary
Public thesis/export asset thesis_f114bfe88a0980bb. Evidence clusters in the synthesis pass target a prioritization gap: constrained candidates currently share ranking space with unconstrained linear peptides. We propose a discriminator for cyclization, disulfide, and high-proline handles separating these candidates from unconstrained linear peptides. Support is structural and assay-adjacent, including Structural metric for sequence GHQMQHHCDDSQPTDCWP and Cyclic Peptide Nanotubes in Deep Eutectic Solvents. Quality by Design-Based Formulation Development of an Oral Semaglutide Tablet constrains interpretation because formulation can shift peptide exposure. Runtime confidence is moderate, with low evidence strength; the §8 panel adjudicates whether separate validation is warranted. Boundary: public research artifact with explicit uncertainty, not biological validation.
